Generally, these results suggested that ANXA5, STAT1, CD44, CAV1, MAPT, and ANXA2 might play a critical role in the pathogenesis of glioma, suggesting that the hub genes might be a promising biomarker of glioma. This evidence concerns the gene CD44 and glioma.